Kyverna Therapeutics

Kyverna Therapeutics is a biotechnology company focused on engineering advanced cell therapies to treat autoimmune and inflammatory diseases. They make money by developing and commercializing innovative therapies that modulate the immune system, aiming to provide long-term remission for patients. Founded in 2018, Kyverna leverages cutting-edge technologies like synthetic biology and gene editing to create their therapeutic products, positioning themselves as a leader in the next generation of immune-modulating treatments.

Recent Posts by Kyverna Therapeutics

1-20 of 128